GKOS ▲ +1.0% - Glaukos Corporation
$GKOS - Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination with Cataract Surgery
09-OCT-2026 07:04 AM ET
Share this post
More filings for $GKOS
GKOS ▼ -0.2% - Glaukos CorporationOct 8, 2026GKOS ▲ +8.5% - Glaukos CorporationOct 7, 2026GKOS ▲ +8.5% - Glaukos CorporationOct 7, 2026GKOS ▼ -0.1% - Glaukos CorporationOct 7, 2026GKOS ▲ +0.0% - Glaukos CorporationSep 23, 2026
View full $GKOS filing history →💬 Comments
Loading comments…
Leave a comment